Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 18

1.

Almost all articles on cancer prognostic markers report statistically significant results.

Kyzas PA, Denaxa-Kyza D, Ioannidis JP.

Eur J Cancer. 2007 Nov;43(17):2559-79. Epub 2007 Nov 5. Review.

PMID:
17981458
2.

Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer.

Callagy GM, Webber MJ, Pharoah PD, Caldas C.

BMC Cancer. 2008 May 29;8:153. doi: 10.1186/1471-2407-8-153. Review.

3.

Primer: an evidence-based approach to prognostic markers.

Altman DG, Riley RD.

Nat Clin Pract Oncol. 2005 Sep;2(9):466-72. Review.

PMID:
16265015
4.
5.

Effect of formal statistical significance on the credibility of observational associations.

Ioannidis JP.

Am J Epidemiol. 2008 Aug 15;168(4):374-83; discussion 384-90. doi: 10.1093/aje/kwn156. Epub 2008 Jul 8. Review.

PMID:
18611956
6.

How much of the data published in observational studies of the association between diet and prostate or bladder cancer is usable for meta-analysis?

Bekkering GE, Harris RJ, Thomas S, Mayer AM, Beynon R, Ness AR, Harbord RM, Bain C, Smith GD, Sterne JA.

Am J Epidemiol. 2008 May 1;167(9):1017-26. doi: 10.1093/aje/kwn005. Epub 2008 Apr 10. Review. Erratum in: Am J Epidemiol. 2009 Aug 15;170(4):536.

PMID:
18403406
7.

Consistency and accuracy of indexing systematic review articles and meta-analyses in medline.

Wilczynski NL, Haynes RB.

Health Info Libr J. 2009 Sep;26(3):203-10. doi: 10.1111/j.1471-1842.2008.00823.x. Review.

8.

Assessing the clinical impact of prognostic factors: when is "statistically significant" clinically useful?

Hayes DF, Trock B, Harris AL.

Breast Cancer Res Treat. 1998;52(1-3):305-19. Review.

PMID:
10066089
9.

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers.

Baak JP, Gudlaugsson E, Skaland I, Guo LH, Klos J, Lende TH, Søiland H, Janssen EA, Zur Hausen A.

Breast Cancer Res Treat. 2009 May;115(2):241-54. doi: 10.1007/s10549-008-0126-y. Epub 2008 Jul 30. Review.

PMID:
18665447
10.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

12.

Assessment of publication bias for the surgeon scientist.

Mahid SS, Qadan M, Hornung CA, Galandiuk S.

Br J Surg. 2008 Aug;95(8):943-9. doi: 10.1002/bjs.6302. Review.

PMID:
18618864
13.

Survival end point reporting in randomized cancer clinical trials: a review of major journals.

Mathoulin-Pelissier S, Gourgou-Bourgade S, Bonnetain F, Kramar A.

J Clin Oncol. 2008 Aug 1;26(22):3721-6. doi: 10.1200/JCO.2007.14.1192. Review.

PMID:
18669458
14.

Prostate cancer and driving occupations: could whole body vibration play a role?

Young E, Kreiger N, Purdham J, Sass-Kortsak A.

Int Arch Occup Environ Health. 2009 Apr;82(5):551-6. doi: 10.1007/s00420-009-0403-z. Epub 2009 Feb 26. Review.

PMID:
19242718
15.

Is everything we eat associated with cancer? A systematic cookbook review.

Schoenfeld JD, Ioannidis JP.

Am J Clin Nutr. 2013 Jan;97(1):127-34. doi: 10.3945/ajcn.112.047142. Epub 2012 Nov 28. Review.

16.

Evaluation of meta-analyses in the otolaryngological literature.

Rudmik LR, Walen SG, Dixon E, Dort J.

Otolaryngol Head Neck Surg. 2008 Aug;139(2):187-94. doi: 10.1016/j.otohns.2008.03.020. Review.

PMID:
18656713
17.

Diagnostic and prognostic molecular markers in renal cell carcinoma.

Tunuguntla HS, Jorda M.

J Urol. 2008 Jun;179(6):2096-102. doi: 10.1016/j.juro.2008.01.083. Epub 2008 Apr 18. Review.

PMID:
18423738
18.

Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond.

Riley RD, Sauerbrei W, Altman DG.

Br J Cancer. 2009 Apr 21;100(8):1219-29. doi: 10.1038/sj.bjc.6604999. Review.

Supplemental Content

Support Center